Reducing health inequalities through general practice.


Journal

The Lancet. Public health
ISSN: 2468-2667
Titre abrégé: Lancet Public Health
Pays: England
ID NLM: 101699003

Informations de publication

Date de publication:
06 2023
Historique:
received: 16 01 2023
revised: 30 03 2023
accepted: 18 04 2023
medline: 29 5 2023
pubmed: 28 5 2023
entrez: 27 5 2023
Statut: ppublish

Résumé

Although general practice can contribute to reducing health inequalities, existing evidence provides little guidance on how this reduction can be achieved. We reviewed interventions influencing health and care inequalities in general practice and developed an action framework for health professionals and decision makers. We conducted a realist review by searching MEDLINE, Embase, CINAHL, PsycINFO, Web of Science, and Cochrane Library for systematic reviews of interventions into health inequality in general practice. We then screened the studies in the included systematic reviews for those that reported their outcomes by socioeconomic status or other PROGRESS-Plus (Cochrane Equity Methods Group) categories. 159 studies were included in the evidence synthesis. Robust evidence on the effect of general practice on health inequalities is scarce. Focusing on common qualities of interventions, we found that to reduce health inequalities, general practice needs to be informed by five key principles: involving coordinated services across the system (ie, connected), accounting for differences within patient groups (ie, intersectional), making allowances for different patient needs and preferences (ie, flexible), integrating patient worldviews and cultural references (ie, inclusive), and engaging communities with service design and delivery (ie, community-centred). Future work should explore how these principles can inform the organisational development of general practice.

Identifiants

pubmed: 37244675
pii: S2468-2667(23)00093-2
doi: 10.1016/S2468-2667(23)00093-2
pii:
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e463-e472

Subventions

Organisme : Department of Health
ID : NIHR 130694
Pays : United Kingdom

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests GW was Deputy Chair of the UK's National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Prioritisation Committee: Integrated Community Health and Social Care (A), HTA Remit and Competitiveness Group, HTA Prioritisation Committee A methods group, and HTA Post-Funding Committee. SS was a member of Public Health Research's Research Funding Board. RH was a member of HTA Prioritisation Committee C (mental health, women, and children's health) and HTA Commissioning Committee. All other authors declare no competing interests.

Auteurs

Anna Gkiouleka (A)

Department of Public Health and Primary Care, Cambridge, UK.

Geoff Wong (G)

University of Cambridge, Cambridge, UK; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.

Sarah Sowden (S)

Population Health Sciences Institute, Newcastle University, Newcastle-upon-Tyne, UK.

Clare Bambra (C)

Population Health Sciences Institute, Newcastle University, Newcastle-upon-Tyne, UK.

Rikke Siersbaek (R)

Centre for Health Policy and Management, Trinity College Dublin, University of Dublin, Dublin, Ireland.

Sukaina Manji (S)

Department of Educational Research, Lancaster University, Lancaster, UK.

Annie Moseley (A)

Norwich, UK.

Isla Kuhn (I)

University of Cambridge Medical Library, School of Clinical Medicine, Cambridge, UK.

John Ford (J)

Wolfson Institute of Population Health, Queen Mary University of London, London, UK. Electronic address: j.a.ford@qmul.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH